NAM
ABEO icon

Nexpoint Asset Management’s Abeona Therapeutics ABEO Stock Holding History

Nexpoint Asset Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-23,131
Closed -$648K – 220
2021
Q3 		$648K Buy
23,131
+3,131
+16% +$100K 0.11% 93
2021
Q2 		$780K Buy
+20,000
New +$816K 0.17% 78

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nexpoint Asset Management's ABEO Position: Q4 2021 in Review

Nexpoint Asset Management sold out of Abeona Therapeutics (ABEO) in Q4 2021, closing a stake of 23,131 shares — an estimated $648K sold.

Nexpoint Asset Management first reported a position in ABEO in Q2 2021 and held it in 2 quarters. The position peaked at $780K in Q2 2021. 52 funds tracked by Wall St. Rank hold ABEO as of Q4 2021.

  • Nexpoint Asset Management reported no remaining Abeona Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Nexpoint Asset Management sold 23,131 Abeona Therapeutics shares in Q4 2021, an estimated $648K.
  • Nexpoint Asset Management first reported a position in Abeona Therapeutics in Q2 2021 and held it in 2 quarters.
  • Nexpoint Asset Management's Abeona Therapeutics position peaked at $780K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2021.

Based on Nexpoint Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.